83-3856-23 Human VEGF165 Protein, His Tag 1mg VE5-H5248-1mg
特徴
- 背景
- VEGF165 is the most abundant splice variant of VEGF-A.
- VEGF165 is produced by a number of cells including endothelial cells, macrophages and T cells.
- VEGF165 is involved in angiogenesis, vascular endothelial cell survival, growth, migration and vascular permeability.
- VEGF gene expression is induced by hypoxia, inflammatory cytokines and oncogenes.
- VEGF165 binds to heparan sulfate and is retained on the cell surface and in the extracellular matrix.
- VEGF165 binds to the receptor tyrosine kinases, VEGFR1 and VEGFR2.
- VEGF165 is the only splice variant that binds to co-receptors NRP-1 and NRP-2 that function to enhance VEGFR2 signaling.
- Binding of VEGF165 to VEGFR1 and VEGFR2 leads to activation of the PI3K/AKT, p38 MAPK, FAK and paxillin.
- VEGF plays a key role in tumor angiogenesis in many cancers.
- 特徴
- This protein carries a polyhistidine tag at the N-terminus.
- The protein has a calculated MW of 21.1 kDa.
- The protein migrates as 25-27 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
仕様
- 容量:1mg
- Source:Human VEGF165, His Tag (VE5-H5248) is expressed from human 293 cells (HEK293). It contains AA Ala 27 - Arg 191 (Accession # P15692-4).
- Species Reactivity:Human
- Host:HEK293
- Tag:N-10×His
- Exp Region:Ala 27 - Arg 191
- Format:Powder
- Conjugate:Unconjugated
- Swiss-Prot:P15692-4
- Protein ID:NP_001165097.1
- Endotoxin:1.0 EU per μg
- Purity:90%
- Buffer:PBS, pH7.4
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]